Literature DB >> 26574898

Clinical spectrum of valosin containing protein (VCP)-opathy.

Mohamed Kazamel1, Eric J Sorenson1, Kathleen M McEvoy1, Lyell K Jones1, Andrea N Leep-Hunderfund1, Michelle L Mauermann1, Margherita Milone1.   

Abstract

INTRODUCTION: Valosin containing protein (VCP) mutations cause a rare disorder characterized by hereditary inclusion body myopathy, Paget disease of bone (PDB), and frontotemporal dementia (FTD) with variable penetrance. VCP mutations have also been linked to amyotrophic lateral sclerosis and Charcot-Marie-Tooth disease type 2.
METHODS: Review of clinical, serological, electrophysiological, and myopathological findings of 6 VCP-opathy patients from 4 unrelated families.
RESULTS: Patients manifested muscle weakness between ages 40 and 53 years and developed predominant asymmetric limb girdle weakness. One patient had distal weakness at onset and co-existing peripheral neuropathy. Another patient had PDB, 1 had mild cognitive deficits, and 1 had FTD. All patients had myopathic and neurogenic electromyographic findings with predominant neurogenic changes in 2. Rimmed vacuoles were infrequent, while neurogenic changes were prominent in muscle biopsies.
CONCLUSIONS: VCP-opathy is a multifaceted disorder in which myopathy and peripheral neuropathy can coexist. The electrophysiological and pathological neurogenic changes raise the possibility of coexisting motor neuron involvement. Muscle Nerve, 2015 Muscle Nerve 54: 94-99, 2016 Muscle Nerve 54: 94-99, 2016.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  FTD; VCP; Valosin containing protein; hereditary IBM; inclusion body myopathy

Mesh:

Substances:

Year:  2015        PMID: 26574898     DOI: 10.1002/mus.24980

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  10 in total

1.  Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78).

Authors:  Alejandro Estrada-Cuzcano; Shaun Martin; Teodora Chamova; Matthis Synofzik; Dagmar Timmann; Tine Holemans; Albena Andreeva; Jennifer Reichbauer; Riet De Rycke; Dae-In Chang; Sarah van Veen; Jean Samuel; Ludger Schöls; Thorsten Pöppel; Danny Mollerup Sørensen; Bob Asselbergh; Christine Klein; Stephan Zuchner; Albena Jordanova; Peter Vangheluwe; Ivailo Tournev; Rebecca Schüle
Journal:  Brain       Date:  2017-02       Impact factor: 13.501

Review 2.  Autophagy in Dictyostelium: Mechanisms, regulation and disease in a simple biomedical model.

Authors:  Ana Mesquita; Elena Cardenal-Muñoz; Eunice Dominguez; Sandra Muñoz-Braceras; Beatriz Nuñez-Corcuera; Ben A Phillips; Luis C Tábara; Qiuhong Xiong; Roberto Coria; Ludwig Eichinger; Pierre Golstein; Jason S King; Thierry Soldati; Olivier Vincent; Ricardo Escalante
Journal:  Autophagy       Date:  2016-10-07       Impact factor: 16.016

Review 3.  Frontotemporal dementia: latest evidence and clinical implications.

Authors:  Juan Joseph Young; Mallika Lavakumar; Deena Tampi; Silpa Balachandran; Rajesh R Tampi
Journal:  Ther Adv Psychopharmacol       Date:  2017-11-10

4.  Whole Exome Sequencing Identifies Atypical Welander Distal Myopathy in Patient.

Authors:  Jennifer Gass; Patrick Blackburn; Jessica Jackson; Kimberly Harris; Duygu Selcen; Elliot Dimberg; Paldeep Atwal
Journal:  J Clin Neuromuscul Dis       Date:  2017-03

5.  Panorama of the distal myopathies.

Authors:  Marco Savarese; Jaakko Sarparanta; Anna Vihola; Per Harald Jonson; Mridul Johari; Salla Rusanen; Peter Hackman; Bjarne Udd
Journal:  Acta Myol       Date:  2020-12-01

Review 6.  Development of a standard of care for patients with valosin-containing protein associated multisystem proteinopathy.

Authors:  Manisha Korb; Allison Peck; Lindsay N Alfano; Kenneth I Berger; Meredith K James; Nupur Ghoshal; Elise Healzer; Claire Henchcliffe; Shaida Khan; Pradeep P A Mammen; Sujata Patel; Gerald Pfeffer; Stuart H Ralston; Bhaskar Roy; William W Seeley; Andrea Swenson; Tahseen Mozaffar; Conrad Weihl; Virginia Kimonis
Journal:  Orphanet J Rare Dis       Date:  2022-01-29       Impact factor: 4.123

7.  The genetic landscape of axonal neuropathies in the middle-aged and elderly: Focus on MME.

Authors:  Jan Senderek; Petra Lassuthova; Dagmara Kabzińska; Lisa Abreu; Jonathan Baets; Christian Beetz; Geir J Braathen; David Brenner; Joline Dalton; Lois Dankwa; Tine Deconinck; Peter De Jonghe; Bianca Dräger; Katja Eggermann; Melina Ellis; Carina Fischer; Tanya Stojkovic; David N Herrmann; Rita Horvath; Helle Høyer; Stephan Iglseder; Marina Kennerson; Katharina Kinslechner; Jennefer N Kohler; Ingo Kurth; Nigel G Laing; Phillipa J Lamont; Löscher Wolfgang N; Albert Ludolph; Wilson Marques; Garth Nicholson; Royston Ong; Susanne Petri; Gianina Ravenscroft; Adriana Rebelo; Giulia Ricci; Sabine Rudnik-Schöneborn; Anja Schirmacher; Beate Schlotter-Weigel; Ludger Schoels; Rebecca Schüle; Matthis Synofzik; Bruno Francou; Tim M Strom; Johannes Wagner; David Walk; Julia Wanschitz; Daniela Weinmann; Jochen Weishaupt; Manuela Wiessner; Reinhard Windhager; Peter Young; Stephan Züchner; Stefan Toegel; Pavel Seeman; Andrzej Kochański; Michaela Auer-Grumbach
Journal:  Neurology       Date:  2020-11-03       Impact factor: 9.910

8.  Phenotypic diversity in an international Cure VCP Disease registry.

Authors:  Chiseko Ikenaga; Andrew R Findlay; Michelle Seiffert; Allison Peck; Nathan Peck; Nicholas E Johnson; Jeffrey M Statland; Conrad C Weihl
Journal:  Orphanet J Rare Dis       Date:  2020-09-29       Impact factor: 4.123

Review 9.  The Role of VCP Mutations in the Spectrum of Amyotrophic Lateral Sclerosis-Frontotemporal Dementia.

Authors:  Eveljn Scarian; Giuseppe Fiamingo; Luca Diamanti; Ilaria Palmieri; Stella Gagliardi; Orietta Pansarasa
Journal:  Front Neurol       Date:  2022-02-22       Impact factor: 4.003

10.  CRISPR/Cas9-engineered Drosophila knock-in models to study VCP diseases.

Authors:  Jordan M Wall; Ankita Basu; Elizabeth R M Zunica; Olga S Dubuisson; Kathryn Pergola; Joshua P Broussard; John P Kirwan; Christopher L Axelrod; Alyssa E Johnson
Journal:  Dis Model Mech       Date:  2021-07-12       Impact factor: 5.758

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.